AT363935B - Verfahren zur herstellung von neuen n-aryl-n(4-piperidinyl)-arylacetamiden und ihren salzen - Google Patents

Verfahren zur herstellung von neuen n-aryl-n(4-piperidinyl)-arylacetamiden und ihren salzen

Info

Publication number
AT363935B
AT363935B AT0702976A AT702976A AT363935B AT 363935 B AT363935 B AT 363935B AT 0702976 A AT0702976 A AT 0702976A AT 702976 A AT702976 A AT 702976A AT 363935 B AT363935 B AT 363935B
Authority
AT
Austria
Prior art keywords
arylacetamides
piperidinyl
aryl
salts
producing new
Prior art date
Application number
AT0702976A
Other languages
German (de)
English (en)
Other versions
ATA702976A (de
Original Assignee
Janssen Pharmaceutica Nv
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Janssen Pharmaceutica Nv filed Critical Janssen Pharmaceutica Nv
Publication of ATA702976A publication Critical patent/ATA702976A/de
Application granted granted Critical
Publication of AT363935B publication Critical patent/AT363935B/de

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D211/00Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings
    • C07D211/04Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D211/68Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having one double bond between ring members or between a ring member and a non-ring member
    • C07D211/72Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having one double bond between ring members or between a ring member and a non-ring member with hetero atoms or with carbon atoms having three bonds to hetero atoms, with at the most one bond to halogen, directly attached to ring carbon atoms
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00Drugs for disorders of the cardiovascular system
    • A61P9/06Antiarrhythmics
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D211/00Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings
    • C07D211/04Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D211/06Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members
    • C07D211/36Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D211/56Nitrogen atoms
    • C07D211/58Nitrogen atoms attached in position 4
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D211/00Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings
    • C07D211/04Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D211/06Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members
    • C07D211/36Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D211/60Carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals
    • C07D211/62Carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals attached in position 4
    • C07D211/66Carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals attached in position 4 having a hetero atom as the second substituent in position 4

Landscapes

  • Organic Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Veterinary Medicine (AREA)
  • Cardiology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Hydrogenated Pyridines (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
AT0702976A 1975-09-23 1976-09-22 Verfahren zur herstellung von neuen n-aryl-n(4-piperidinyl)-arylacetamiden und ihren salzen AT363935B (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US61513175A 1975-09-23 1975-09-23
US71375676A 1976-08-12 1976-08-12

Publications (2)

Publication Number Publication Date
ATA702976A ATA702976A (de) 1981-02-15
AT363935B true AT363935B (de) 1981-09-10

Family

ID=27087421

Family Applications (1)

Application Number Title Priority Date Filing Date
AT0702976A AT363935B (de) 1975-09-23 1976-09-22 Verfahren zur herstellung von neuen n-aryl-n(4-piperidinyl)-arylacetamiden und ihren salzen

Country Status (29)

Country Link
JP (1) JPS6016417B2 (da)
AT (1) AT363935B (da)
AU (1) AU510029B2 (da)
BG (1) BG27543A3 (da)
CA (1) CA1068271A (da)
CH (1) CH628623A5 (da)
CS (1) CS222663B2 (da)
DE (1) DE2642856A1 (da)
DK (1) DK150478C (da)
ES (1) ES451768A1 (da)
FI (1) FI61482C (da)
FR (1) FR2325377A1 (da)
GB (1) GB1539473A (da)
GR (1) GR58469B (da)
HU (1) HU172964B (da)
IE (1) IE43802B1 (da)
IL (1) IL50522A (da)
IT (1) IT1073893B (da)
LU (1) LU75837A1 (da)
NL (1) NL187267C (da)
NO (1) NO147672C (da)
NZ (1) NZ181972A (da)
PH (1) PH12497A (da)
PL (2) PL117323B1 (da)
PT (1) PT65631B (da)
RO (1) RO70079A (da)
SE (1) SE427839B (da)
SU (1) SU747424A3 (da)
YU (1) YU39973B (da)

Families Citing this family (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ZA765684B (en) * 1975-09-23 1978-04-26 Janssen Pharmaceutica Nv Novel n-aryl-n-(1-l-4-piperidinyl)-arylacetamides
JPS62260786A (ja) * 1986-05-08 1987-11-13 株式会社ヘキトク 燻瓦の製造ラインにおける焼成工程後の表面仕上げ装置
JO2769B1 (en) 2005-10-26 2014-03-15 جانسين فارماسوتيكا ان. في Rapid decomposition of physiologically antagonistic agents of the 2-dopamine receptor
JO2642B1 (en) 2006-12-08 2012-06-17 جانسين فارماسوتيكا ان. في Dopamine 2 receptor antagonists are rapidly hydrolyzed
JO2849B1 (en) 2007-02-13 2015-03-15 جانسين فارماسوتيكا ان. في Dopamine 2 receptor antagonists are rapidly hydrolyzed
AU2008240727C1 (en) * 2007-04-23 2013-10-03 Janssen Pharmaceutica N.V. Pyridine derivatives as fast dissociating dopamine 2 receptor antagonists
CN101663292A (zh) 2007-04-23 2010-03-03 詹森药业有限公司 作为快速解离的多巴胺2受体拮抗剂的4-烷氧基哒嗪衍生物
CA2682671C (en) 2007-04-23 2015-11-17 Janssen Pharmaceutica N.V. Thia(dia)zoles as fast dissociating dopamine 2 receptor antagonists
CN102159554B (zh) 2008-07-03 2014-09-24 詹森药业有限公司 作为5-ht6受体拮抗剂的取代的6-(1-哌嗪基)-哒嗪
LT2307374T (lt) 2008-07-31 2017-04-25 Janssen Pharmaceutica Nv Piperazin-1-il-trifluormetil-pakeistieji piridinai kaip greitai disocijuojantys dopamino 2 receptoriaus antagonistai

Also Published As

Publication number Publication date
GR58469B (en) 1977-10-14
FR2325377B1 (da) 1980-04-18
HU172964B (hu) 1979-01-28
PH12497A (en) 1979-04-05
RO70079A (ro) 1982-10-26
LU75837A1 (da) 1977-05-04
JPS5239683A (en) 1977-03-28
FI61482C (fi) 1982-08-10
NZ181972A (en) 1978-07-28
CH628623A5 (en) 1982-03-15
AU510029B2 (en) 1980-06-05
DE2642856C2 (da) 1990-06-21
AU1787876A (en) 1978-03-23
PL192578A1 (pl) 1979-02-26
ES451768A1 (es) 1978-05-01
FI762698A (da) 1977-03-24
NO763054L (no) 1977-03-24
JPS6016417B2 (ja) 1985-04-25
BG27543A3 (en) 1979-11-12
SU747424A3 (ru) 1980-07-23
CS222663B2 (en) 1983-07-29
NO147672C (no) 1983-05-25
FI61482B (fi) 1982-04-30
YU39973B (en) 1985-06-30
PL117323B1 (en) 1981-07-31
IL50522A (en) 1979-09-30
NL187267B (nl) 1991-03-01
IE43802B1 (en) 1981-06-03
SE427839B (sv) 1983-05-09
NL7610513A (nl) 1977-03-25
DK150478C (da) 1987-10-05
YU233676A (en) 1983-01-21
CA1068271A (en) 1979-12-18
IE43802L (en) 1977-03-23
IT1073893B (it) 1985-04-17
GB1539473A (en) 1979-01-31
PT65631A (en) 1976-10-01
ATA702976A (de) 1981-02-15
PT65631B (en) 1978-07-05
SE7610501L (sv) 1977-03-24
DK427876A (da) 1977-03-24
NL187267C (nl) 1991-08-01
DE2642856A1 (de) 1977-03-24
FR2325377A1 (fr) 1977-04-22
DK150478B (da) 1987-03-09
IL50522A0 (en) 1976-11-30
NO147672B (no) 1983-02-14

Similar Documents

Publication Publication Date Title
AT350567B (de) Verfahren zur herstellung von neuen 1,3,4- trisubstituierten 4-arylpiperidinen und ihren salzen
AT352128B (de) Verfahren zur herstellung von neuen 1-substituierten-4-benzylidenpiperidinen und ihren salzen
ATA523978A (de) Verfahren zur herstellung von neuen basischen thioaethern und ihren salzen
AT358597B (de) Verfahren zur herstellung von neuen dihydro- uracilen und ihren salzen
ATA487977A (de) Verfahren zur herstellung von neuen thieno- pyridinderivaten und ihren salzen
AT363935B (de) Verfahren zur herstellung von neuen n-aryl-n(4-piperidinyl)-arylacetamiden und ihren salzen
AT353970B (de) Verfahren zur herstellung von neuen 7-methoxy- cephalosporinen und deren salzen
AT348518B (de) Verfahren zur herstellung von neuen 2-thiol- 4,5-diphenyloxazol-s-derivaten und ihren salzen
AT353257B (de) Verfahren zur herstellung von neuen dibenzo- furanderivaten und ihren salzen
ATA602576A (de) Verfahren zur herstellung von neuen tert- -butylaminopropoxy-indolen und ihren saeure- additionssalzen
AT359060B (de) Verfahren zur herstellung von neuen benz-acyl- benzimidazol-2-derivaten und ihren salzen
AT347946B (de) Verfahren zur herstellung von neuen 1h- tetrazolderivaten und ihren salzen
AT342034B (de) Verfahren zur herstellung von neuen 4,4-diphenyl-2-hydroxybutylaminen und ihren salzen
AT363948B (de) Verfahren zur herstellung von neuen heterocyclopyrimidinen und ihren salzen
AT352724B (de) Verfahren zur herstellung von neuen substi- tuierten sulfoximiden und deren salzen
AT341529B (de) Verfahren zur herstellung von neuen azatetracyclen und ihren salzen
AT373256B (de) Verfahren zur herstellung von neuen benzocycloheptapyridinen und ihren salzen
AT355569B (de) Verfahren zur herstellung von neuen, substi- tuierten pyridoindolen und ihren salzen
AT358027B (de) Verfahren zur herstellung von neuen indol- derivaten und ihren salzen
AT357535B (de) Verfahren zur herstellung von neuen 4-amino- transdecahydrochinolinderivaten und ihren saeureadditionssalzen
AT358013B (de) Verfahren zur herstellung von neuen aryloxy- alkyl-p-aminobenzoesaeuren, deren salzen und estern
AT363620B (de) Verfahren zur herstellung von neuen dimeren 1formylindoldihydroindolen und ihren salzen
AT356113B (de) Verfahren zur herstellung von neuen chinazolin- derivaten und ihren salzen
ATA668277A (de) Verfahren zur herstellung von neuen 4-hydroxy- indol-derivaten und ihren salzen
ATA363080A (de) Verfahren zur herstellung von neuen cyproheptadinderivaten und ihren salzen

Legal Events

Date Code Title Description
ELJ Ceased due to non-payment of the annual fee